CDMO: Avid Bioservices, Inc Broker Consensus Forecast

This price chart for Avid Bioservices, Inc. (CDMO) illustrates the asset's dynamics, with a value of 12.55. The business relies on multi-year contracts that guarantee a predictable cash flow. High customer loyalty is driven by the complex integration of clients' cell structures into production cycles. A developed network of chemical component suppliers provides additional stability, mitigating the risks of dependence on individual counterparties.

CDMO Avid Bioservices, Inc: Price Target Chart in the range 07/04/2022 - 02/16/2025

Analytical breakdowns for Avid Bioservices, Inc (CDMO)

- market price and analyst price targets:

Stock Quotes avidbio.com|CDMO - Analyst Consensus Forecast

- market capitalization information:

Market Capitalization Avid Bioservices, Inc|CDMO - Total Company Value

- business book valuation details:

Accounting Value per Share Avid Bioservices|CDMO - Company Book Value|Market-to-Book Ratio avidbio.com|CDMO - Aggregate Company Assets

- issuer credit burden and liquidity indicators:

Aggregate Debt to Equity Avid Bioservices, Inc.|CDMO - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Avid Bioservices Inc|CDMO - Company Aggregate Debts|Debts to Book Capitalization Avid Bioservices, Inc|CDMO - Company Long-Term Debt|Company Short-Term Loans and Borrowings Avid Bioservices|Quick Liquidity Indicator avidbio.com

- business earnings and investment ratios data:

CDMO - Net Profit|Projected Future Earnings Avid Bioservices, Inc.|CDMO - Price to Earnings Ratio|Future Price to Earnings Multiple Avid Bioservices Inc.|CDMO - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Avid Bioservices, Inc|CDMO - Operating profit EBITDA|Net earnings per one share for the last twelve months Avid Bioservices|CDMO - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months avidbio.com|CDMO - Net earnings per share growth this year|Projected earnings per share increase next year Avid Bioservices, Inc.

General company analysis:CDMO avidbio.com

Flagship merchandise of Avid Bioservices Inc

A comparative asset analysis requires evaluating the average target price from leading investment banks, which allows market panic to be distinguished from actual business devaluation. This consensus valuation metric aggregates expert expectations, confirming the resilience of Avid Bioservices, Inc. (CDMO) given its stable order book and secure liquidity levels, even amidst a dependence on clients' capital expenditures for bioreactors.

Competitors of Avid Bioservices, Inc.